Natural products-based drug design against SARS-CoV-2 Mpro 3CLpro (2021)
Source: International Journal of Molecular Sciences. Unidades: FCFRP, FFCLRP
Subjects: COVID-19, PRODUTOS NATURAIS, SAÚDE PÚBLICA, FARMACOCINÉTICA, ANÁLISE TOXICOLÓGICA
ABNT
SILVA, Rai Campos; PITA, Samuel S. R.; SANTOS, Cleydson B. R.; et al. Natural products-based drug design against SARS-CoV-2 Mpro 3CLpro. International Journal of Molecular Sciences, Basel, v. 22, n. 21, p. 1-24, 2021. Disponível em: < https://doi.org/10.3390/ijms222111739 > DOI: 10.3390/ijms222111739.APA
Silva, R. C., Pita, S. S. R., Santos, C. B. R., Borges, R. S., Freitas, H. F., Campos, J. M., et al. (2021). Natural products-based drug design against SARS-CoV-2 Mpro 3CLpro. International Journal of Molecular Sciences, 22( 21), 1-24. doi:10.3390/ijms222111739NLM
Silva RC, Pita SSR, Santos CBR, Borges RS, Freitas HF, Campos JM, Kimani NM, Silva CHT de P da. Natural products-based drug design against SARS-CoV-2 Mpro 3CLpro [Internet]. International Journal of Molecular Sciences. 2021 ; 22( 21): 1-24.Available from: https://doi.org/10.3390/ijms222111739Vancouver
Silva RC, Pita SSR, Santos CBR, Borges RS, Freitas HF, Campos JM, Kimani NM, Silva CHT de P da. Natural products-based drug design against SARS-CoV-2 Mpro 3CLpro [Internet]. International Journal of Molecular Sciences. 2021 ; 22( 21): 1-24.Available from: https://doi.org/10.3390/ijms222111739